Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GERON CORP | 220,000 | reported | 20 May 2026 | tx 96+1,820,464−453,351 |
| PDS Biotechnology Corp | 48,661 | reported | 15 Mar 2019 | tx 12+108,661−56,667 |
| RenovoRx, Inc. | 47,640 | reported | 01 Oct 2025 | tx 6+222,830 |
| XCYTE THERAPIES INC | 39,415 | reported | 30 Jun 2023 | tx 9+150,772 |
| ORTHOLOGIC CORP | 10,000 | reported | 01 Jan 2012 | tx 4+80,000 |
| PTC THERAPEUTICS, INC. | 10,000 | reported | 04 Jan 2016 | tx 6+171,186−1,030 |
| Athenex, Inc. | 4,592 | reported | 21 Apr 2023 | tx 11+90,422−8,750 |
| Advaxis, Inc. | 1,171 | reported | 19 Jan 2023 | tx 4+7,963 |
| Sucampo Pharmaceuticals, Inc. | 0 | reported | 13 Feb 2018 | tx 9+74,930−65,130 |
| Hana Biosciences Inc | 0 | reported | 17 Jul 2013 | tx 8+145,000−115,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | GRANT_AWARD | GERON CORP | 220,000 | 0.00 USD | deriv |
| 31 Dec 2025 | GRANT_AWARD | GERON CORP | 5,918 | 1.32 USD | |
| 01 Oct 2025 | GRANT_AWARD | RenovoRx, Inc. | 47,640 | 0.00 USD | deriv |
| 30 Sept 2025 | GRANT_AWARD | GERON CORP | 5,702 | 1.37 USD | |
| 30 Jun 2025 | GRANT_AWARD | GERON CORP | 5,540 | 1.41 USD | |
| 21 May 2025 | GRANT_AWARD | GERON CORP | 180,000 | 0.00 USD | deriv |
| 31 Mar 2025 | GRANT_AWARD | GERON CORP | 4,913 | 1.59 USD | |
| 31 Dec 2024 | GRANT_AWARD | GERON CORP | 2,206 | 0.00 USD | |
| 01 Oct 2024 | GRANT_AWARD | RenovoRx, Inc. | 25,099 | 0.00 USD | deriv |
| 30 Sept 2024 | GRANT_AWARD | GERON CORP | 1,767 | 0.00 USD | |
| 28 Jun 2024 | GRANT_AWARD | GERON CORP | 1,916 | 0.00 USD | |
| 29 Mar 2024 | GRANT_AWARD | GERON CORP | 2,462 | 0.00 USD | |
| 09 May 2024 | GRANT_AWARD | GERON CORP | 180,000 | 0.00 USD | deriv |
| 26 Jan 2024 | PURCHASE | RenovoRx, Inc. | 40,983 | — | |
| 26 Jan 2024 | PURCHASE | RenovoRx, Inc. | 40,983 | — | derivfirst after silence |
| 29 Dec 2023 | GRANT_AWARD | GERON CORP | 3,406 | 0.00 USD | |
| 29 Sept 2023 | GRANT_AWARD | GERON CORP | 3,390 | 0.00 USD | |
| 01 Oct 2023 | GRANT_AWARD | RenovoRx, Inc. | 25,099 | 0.00 USD | deriv |
| 30 Jun 2023 | GRANT_AWARD | XCYTE THERAPIES INC | 21,219 | 0.00 USD | |
| 30 Jun 2023 | GRANT_AWARD | XCYTE THERAPIES INC | 42,438 | 0.00 USD | deriv |
| 30 Jun 2023 | GRANT_AWARD | GERON CORP | 2,239 | 0.00 USD | |
| 31 May 2023 | GRANT_AWARD | GERON CORP | 125,000 | 0.00 USD | deriv |
| 25 Apr 2023 | GRANT_AWARD | RenovoRx, Inc. | 43,026 | 0.00 USD | deriv |
| 21 Apr 2023 | GRANT_AWARD | Athenex, Inc. | 2,300 | 1.31 USD | |
| 31 Mar 2023 | GRANT_AWARD | GERON CORP | 3,312 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 26 Jan 2024.